LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

LLY

701.97

+2.52%↑

JNJ

176.85

+1.02%↑

ABBV

206.8

+1%↑

NVS

123.84

+1.28%↑

AZN

79.17

+0.81%↑

Search

Certara Inc

Slēgts

SektorsVeselības aprūpe

11.02 0.27

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

10.9

Max

11.06

Galvenie mērījumi

By Trading Economics

Ienākumi

-6.7M

-2M

Pārdošana

-1.4M

105M

P/E

Sektora vidējais

209.4

34.427

EPS

0.029

Peļņas marža

-1.882

Darbinieki

1,487

EBITDA

29M

30M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+28.58% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

69M

1.7B

Iepriekšējā atvēršanas cena

10.75

Iepriekšējā slēgšanas cena

11.02

Ziņu noskaņojums

By Acuity

25%

75%

54 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

Certara Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 15. aug. 16:11 UTC

Galvenie tirgus virzītāji

Health Insurers Climb as Berkshire Hathaway Takes UnitedHealth Stake

2025. g. 15. aug. 22:22 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 15. aug. 22:22 UTC

Tirgus saruna

Target Is Falling Behind Its Peers -- Market Talk

2025. g. 15. aug. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 15. aug. 20:33 UTC

Tirgus saruna

U.S. Treasury Yields Close the Week Little Changed -- Market Talk

2025. g. 15. aug. 20:25 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

This Meatpacker Stock Is a Quality Buy at a Discount Price -- Barrons.com

2025. g. 15. aug. 20:24 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

2025. g. 15. aug. 20:18 UTC

Peļņas

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

2025. g. 15. aug. 19:14 UTC

Tirgus saruna

U.S. Natural Gas Settles Higher, But Down on Week -- Market Talk

2025. g. 15. aug. 19:12 UTC

Tirgus saruna

Oil Futures Settle Lower Ahead of U.S.-Russia Summit -- Market Talk

2025. g. 15. aug. 18:32 UTC

Tirgus saruna

Coffee Futures Surge on New Brazilian Frost -- Market Talk

2025. g. 15. aug. 17:33 UTC

Tirgus saruna

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

2025. g. 15. aug. 17:23 UTC

Tirgus saruna
Peļņas

Deere's Earnings Appear to Be Troughing -- Market Talk

2025. g. 15. aug. 16:27 UTC

Peļņas

Tariffs Have Rocked e.l.f. Beauty Shares. Why the Fundamentals Still Look Alluring. -- Barrons.com

2025. g. 15. aug. 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 15. aug. 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 15. aug. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 15. aug. 16:05 UTC

Iegādes, apvienošanās, pārņemšana

Intel's Move Toward Nationalization Won't Work -- at Least for the Long Haul -- Heard on the Street -- WSJ

2025. g. 15. aug. 15:52 UTC

Iegādes, apvienošanās, pārņemšana

What Applied Materials' Poor Outlook Means for Chip Stocks -- Barrons.com

2025. g. 15. aug. 15:36 UTC

Tirgus saruna

Base Metal Prices Mixed; Copper Gains as Focus Shifts to Fundamentals -- Market Talk

2025. g. 15. aug. 15:29 UTC

Peļņas

Deere's Earnings Brought a Surprise. It Wasn't the Usual Kind. -- Barrons.com

2025. g. 15. aug. 15:29 UTC

Iegādes, apvienošanās, pārņemšana

Nucor Stock Gets a Boost From Buffett. Berkshire's Last Steel Buy Didn't Go So Well. -- Barrons.com

2025. g. 15. aug. 15:28 UTC

Peļņas

JD.com Stock Rises After Earnings Beat. Why Investors Are Relieved. -- Barrons.com

2025. g. 15. aug. 15:24 UTC

Tirgus saruna

Gold Futures Tick Higher But Remain Broadly Rangebound -- Market Talk

2025. g. 15. aug. 15:08 UTC

Tirgus saruna

Applied Materials Is Losing Share in Chips Business -- Market Talk

2025. g. 15. aug. 14:38 UTC

Iegādes, apvienošanās, pārņemšana

African Rainbow Minerals to Own 19.9% of Surge Copper Shares

2025. g. 15. aug. 14:37 UTC

Iegādes, apvienošanās, pārņemšana

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares for C$4.51M

2025. g. 15. aug. 14:37 UTC

Iegādes, apvienošanās, pārņemšana

African Rainbow Minerals to Buy 25.8 Million Surge Copper Shares at C$0.175 Each

2025. g. 15. aug. 14:36 UTC

Iegādes, apvienošanās, pārņemšana

African Rainbow Minerals to Acquire Shares of Surge Copper Corp.

2025. g. 15. aug. 14:33 UTC

Iegādes, apvienošanās, pārņemšana

A Trump Intel Stake Could Make National Security the New 'Too Big to Fail' -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Certara Inc Prognoze

Cenas mērķis

By TipRanks

28.58% augšup

Prognoze 12 mēnešiem

Vidējais 14.17 USD  28.58%

Augstākais 16 USD

Zemākais 11.5 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Certara Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

7 ratings

4

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

11.27 / 12.79Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Very Strong Bullish Evidence

Ilgtermiņā

Strong Bullish Evidence

Noskaņojums

By Acuity

54 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Vidējais

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.